| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr1_0871100 | Intergenic-Intergenic | chr1:41605160-41606280 | chr1:41139488-41140608 | 1121 nt | 0.3640 |
| hsa_SCMH1_0010900 | Intron-Exon-Intron | chr1:41608546-41617356 | chr1:41142874-41151684 | 310 nt | 0.5032 |
| hsa_SCMH1_0011200 | Intron-Exon-Intron | chr1:41608546-41618413 | chr1:41142874-41152741 | 214 nt | 0.4813 |
| hsa_SCMH1_0011000 | Intron-Exon | chr1:41608546-41627104 | chr1:41142874-41161432 | 612 nt | 0.4281 |
| hsa_SCMH1_0011100 | Intron-Exon-Intron | chr1:41608546-41651922 | chr1:41142874-41186250 | 742 nt | 0.4259 |
| hsa_SCMH1_0011600 | Exon-Exon | chr1:41608550-41608784 | chr1:41142878-41143112 | 235 nt | 0.5191 |
| hsa_SCMH1_0011700 | Exon-Exon | chr1:41608550-41627104 | chr1:41142878-41161432 | 328 nt | 0.4909 |
| hsa_SCMH1_0011800 | Exon-Exon | chr1:41608550-41651922 | chr1:41142878-41186250 | 223 nt | 0.4170 |
| hsa_SCMH1_0011900 | Intron-Exon-Intron | chr1:41608550-41668919 | chr1:41142878-41203247 | 65 nt | 0.2615 |
| hsa_SCMH1_0012000 | Intron-Exon-Intron | chr1:41608550-41678544 | chr1:41142878-41212872 | 35 nt | 0.4286 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].